Update on Novo Nordisk manufacturing deviation for NovoSeven©, resulting in shortages for NovoEight© and Esperoct©
Other resources
European Medicines Agency (EMA) reports a supply shortage of NovoSeven in several EU countries
The supply shortage or limited availability affects some of the EU Member States where the medicine is marketed, including Belgium, Denmark, France, Germany, Luxembourg and Sweden; in some Member States, English-labelled packs for certain doses will be available until the end of 2025.
EHC Supports the Statement by ISTH, EAHAD, and WFH on Critical Juncture in Haemophilia Treatment
The EHC joins the International Society on Thrombosis and Haemostasis (ISTH), European Association for Haemophilia and Allied Disorders (EAHAD), World Federation of Hemophilia (WFH), and other leading international organisations in issuing a statement and urgent call-to-action for a continued commitment to innovation and access in haemophilia care.